UPLC/MS technologies supporting development of nucleic acid related modalities was written by Hirose, Kenji. And the article was included in BIO Clinica in 2021.Related Products of 1224606-06-7 The following contents are mentioned in the article:
With the rapid development of nucleic acid-related drug modality, there is also a need for generalization of anal. techniques for precise evaluation of their quality. The mol. structure of nucleic acid-related drugs is complex and highly controlled, and requires technol. to analyze more items with higher accuracy than evaluation tests conducted on general small mol. drugs. Here, the author introduced the latest technologies of Ultraperformance Liquid Chromatog. (UPC) and Mass Spectrometry (MS), which have performance suitable for the structural properties of these new modalities, with actual examples. This study involved multiple reactions and reactants, such as (6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate (cas: 1224606-06-7Related Products of 1224606-06-7).
(6Z,9Z,28Z,31Z)-Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate (cas: 1224606-06-7) belongs to esters. Carboxylic acid esters of low molecular weight are colourless, volatile liquids with pleasant odours, slightly soluble in water. Esterification is the general name for a chemical reaction in which two reactants (typically an alcohol and an acid) form an ester as the reaction product. Esters are common in organic chemistry and biological materials.Related Products of 1224606-06-7
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics